ArticleBMC pulmonary medicine2025
Case report: refractory atelectasis after infection of adenovirus and Mycoplasma Pneumoniae in an immunocompetent patient.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAtelectasis is defined as collapse of alveolar spaces due to a variety of reasons. Most atelectasis could improve after removing the cause by chest physiotherapy, medical treatment, therapeutic bronchoscopy and so on. However, some atelectasis cannot be cleared with above treatments, resulting in long-term atelectasis, also called as refractory atelectasis. It easily leads to recurrent infection, bronchiectasis, bronchiolitis obliterans, and lung necrosis. So, it is important to identify causal mechanism of refractory atelectasis, which may contribute to explore effective approach and reducing complications. CASE PRESENTATION: We present the case of a 4-years-old girl admitted to hospital with fever and cough for 6 days, who had pulmonary consolidation in left lower lobe due to human adenovirus-7 and Mycoplasma pneumoniae. Although the patient did not have inborn errors of immunity, neuromuscular disease or inherited metabolic diseases through medical history and laboratory examination, the consolidation of the left lower lung still existed after a series of treatments, including mechanical ventilation, intravenous immunoglobulin, systemic corticosteroid, azithromycin and bronchoalveolar lavage. Even, chest HRCT showed left lung atelectasis one month after discharge. In the follow-up 1 years, she was hospitalized for respiratory infections and wheezing 4 times. In consideration of refractory atelectasis and recurrent infections, left lung was resected by thoracoscopy and postoperative pathology confirmed bronchiolitis obliterans. Specific antibodies was utilized to identify type I and II alveolar epithelial cells, club cells, ionocytes and ciliated cells respectively, which show a selective reduction in type I alveolar epithelial cells.
conclusionIt is rare that a previously healthy child developed to refractory atelectasis after an infection which ultimately resulted in a lobectomy. The cellular analysis of the atrophic lung tissue showed a selective reduction in type I alveolar epithelial cells.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.